21st century excitatory amino acid research: A Q & A with Jeff Watkins and Dick Evans.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
15 10 2021
Historique:
pubmed: 8 8 2021
medline: 5 2 2022
entrez: 7 8 2021
Statut: ppublish

Résumé

In 1981 Jeff Watkins and Dick Evans wrote what was to become a seminal review on excitatory amino acids (EAAs) and their receptors (Watkins and Evans, 1981). Bringing together various lines of evidence dating back over several decades on: the distribution in the nervous system of putative amino acid neurotransmitters; enzymes involved in their production and metabolism; the uptake and release of amino acids; binding of EAAs to membranes; the pharmacological action of endogenous excitatory amino acids and their synthetic analogues, and notably the actions of antagonists for the excitations caused by both nerve stimulation and exogenous agonists, often using pharmacological tools developed by Jeff and his colleagues, they provided a compelling account for EAAs, especially l-glutamate, as a bona fide neurotransmitter in the nervous system. The rest, as they say, is history, but far from being consigned to history, EAA research is in rude health well into the 21st Century as this series of Special Issues of Neuropharmacology exemplifies. With EAAs and their receptors flourishing across a wide range of disciplines and clinical conditions, we enter into a dialogue with two of the most prominent and influential figures in the early days of EAA research: Jeff Watkins and Dick Evans.

Identifiants

pubmed: 34363811
pii: S0028-3908(21)00298-7
doi: 10.1016/j.neuropharm.2021.108743
pii:
doi:

Substances chimiques

Excitatory Amino Acids 0
Neurotransmitter Agents 0
Receptors, Glutamate 0

Types de publication

Interview

Langues

eng

Sous-ensembles de citation

IM

Pagination

108743

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Àlex Bayés (À)

Molecular Physiology of the Synapse Laboratory, Biomedical Research Institute Sant Pau, Barcelona, Spain and Universitat Autònoma de Barcelona, Barcelona, Spain.

Sam A Booker (SA)

Simons Initiative for the Developing Brain, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.

Alasdair Gibb (A)

Research Department of Neuroscience, Physiology & Pharmacology, University College London, Gower Street, London, WC1E 6BT, UK.

Angela M Mabb (AM)

Neuroscience Institute, Georgia State University, Atlanta, GA, United States.

Mark Mayer (M)

Bldg 35A, Room 3D-904, 35A Convent Drive, NINDS, NIH, Bethesda, MD, 20892, USA.

Jack R Mellor (JR)

School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, UK.

Elek Molnár (E)

School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, UK.

Li Niu (L)

Chemistry Department, University at Albany, SUNY, 1400 Washington Ave, Albany, NY, 12222, USA.

Arturo Ortega (A)

Department of Toxicology, Cinvestav, Mexico City, Mexico.

Yuriy Pankratov (Y)

School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.

David Ramos-Vicente (D)

Molecular Physiology of the Synapse Laboratory, Biomedical Research Institute Sant Pau, Barcelona, Spain and Universitat Autònoma de Barcelona, Barcelona, Spain.

Ada Rodríguez-Campuzano (A)

Department of Toxicology, Cinvestav, Mexico City, Mexico.

Antonio Rodríguez-Moreno (A)

Universidad Pablo de Olavide, ES-41013, Seville, Spain.

Lu-Yang Wang (LY)

Program in Neurosciences & Mental Health, SickKids Research Institute and Department of Physiology, University of Toronto, 555 University Ave, Toronto, Ontario, M5G 1X8, Canada.

Yu Tian Wang (YT)

Department of Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada.

Lonnie Wollmuth (L)

Depts. of Neurobiology & Behavior and Biochemistry & Cell Biology, Center for Nervous System Disorders, Stony Brook University, Stony Brook, NY, 11794-5230, USA.

David J A Wyllie (DJA)

Simons Initiative for the Developing Brain, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.

Min Zhuo (M)

Institute of Brain Research, Qingdao International Academician Park, Qingdao, 266000, China.

Bruno G Frenguelli (BG)

School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK. Electronic address: b.g.frenguelli@warwick.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH